Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
1.
Spine (Phila Pa 1976) ; 42(7): E392-E397, 2017 Apr 01.
Article in English | MEDLINE | ID: mdl-28351070

ABSTRACT

STUDY DESIGN: Retrospective review. OBJECTIVE: To evaluate key risk factors for the development of C5 palsy after cervical corpectomy, including resection of the posterior longitudinal ligament (PLL). SUMMARY OF BACKGROUND DATA: Postoperative C5 palsy is a well-known complication after cervical spine surgery. It is unknown whether resection of the PLL affects the incidence of C5 palsy. METHODS: We performed a retrospective review of 459 consecutive patients undergoing anterior cervical corpectomies over a 15-year period. Medical records were reviewed to gather demographic data, operative details, and the incidence of C5 palsy. We performed regression analyses to identify variables that predicted the development of C5 palsy. RESULTS: Our final analysis included 397 patients (females 51.4%, mean age 55.6 ±â€Š11.6 yrs). Anterior corpectomy alone was performed in 255 (64.2%) patients, and combined anterior and posterior fusion was performed in 142 (35.8%) patients. Twenty-four patients (6.0%) developed C5 nerve palsy. Univariable regression demonstrated age greater than 65 (odds ratio, OR 2.7, 95% confidence interval, CI 1.2 to 6.3), corpectomy of three or more levels (OR 6.3, 95% CI 2.1 to 18.9), presence of ossification of the PLL (OR 4.3, 95% CI 1.6 to 11.7), and complete or partial resection of the PLL (OR 2.6, 95% CI 1.0 to 6.7) predicted development of C5 palsy. Multivariable regression demonstrated that the odds of getting C5 palsy with complete or partial resection of the PLL is 4.0 times (95% CI 1.5 to 10.5) higher compared with patients with an intact PLL. There were no significant differences in C5 palsy rates based on surgical approach (anterior vs. anterior plus posterior), sex, smoking status, or diabetes. CONCLUSION: Age greater than 65 years, corpectomy of three or more levels, presence of ossification of the PLL, and complete or partial resection of the PLL significantly predicted the development of C5 palsy. LEVEL OF EVIDENCE: 4.


Subject(s)
Cervical Vertebrae/surgery , Laminectomy/adverse effects , Longitudinal Ligaments/surgery , Paralysis/epidemiology , Postoperative Complications/epidemiology , Spinal Fusion/adverse effects , Adult , Aged , Female , Humans , Incidence , Male , Middle Aged , Paralysis/diagnosis , Postoperative Complications/diagnosis , Retrospective Studies
2.
Biomaterials ; 112: 62-71, 2017 01.
Article in English | MEDLINE | ID: mdl-27744221

ABSTRACT

Many mechanisms contribute to the secondary injury cascades following traumatic spinal cord injury (SCI). However, most current treatment strategies only target one or a few elements in the injury cascades, and have been largely unsuccessful in clinical trials. Minocycline hydrochloride (MH) is a clinically available antibiotic and anti-inflammatory drug that has been shown to target a broad range of secondary injury mechanisms via its anti-inflammatory, anti-oxidant, and anti-apoptotic properties. However, MH is only neuroprotective at high concentrations. The inability to translate the high doses of MH used in experimental animals to tolerable doses in human patients limits its clinical efficacy. In addition, the duration of MH treatment is limited because long-term systemic administration of high doses of MH has been shown to cause liver toxicity and even death. We have developed a drug delivery system in the form of hydrogel loaded with polysaccharide-MH complexes self-assembled by metal ions for controlled release of MH. This drug delivery system can be injected into the intrathecal space for local delivery of MH with sufficient dose and duration, without causing any additional tissue damage. We show that local delivery of MH at a dose that is lower than the standard human dose (3 mg/kg) was more effective in reducing secondary injury and promoting locomotor functional recovery than systemic injection of MH with the highest dose and duration reported in experimental animal SCI (90-135 mg/kg).


Subject(s)
Drug Implants/administration & dosage , Metal Nanoparticles/chemistry , Minocycline/administration & dosage , Nerve Regeneration/drug effects , Recovery of Function/drug effects , Spinal Cord Injuries/drug therapy , Spinal Cord Injuries/physiopathology , Animals , Crystallization/methods , Drug Implants/chemistry , Female , Hydrogels/chemistry , Ions , Metal Nanoparticles/administration & dosage , Minocycline/chemistry , Nanocapsules/administration & dosage , Nanocapsules/chemistry , Nanocapsules/ultrastructure , Neuroprotective Agents/administration & dosage , Neuroprotective Agents/chemistry , Rats , Rats, Sprague-Dawley , Spinal Cord Injuries/pathology , Treatment Outcome
3.
J Am Acad Orthop Surg ; 23(8): 492-500, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26116851

ABSTRACT

Upper extremity pain can result from many overlapping etiologies. These can be categorized into anatomic regions and specific organ systems. Anatomically, pain etiologies are classified into four major groups: neurologic, musculoskeletal, vascular, and other (eg, tumor, infection). Knowledge of the characteristic clinical presentation and physical examination findings of each group can help distinguish the source of the patient's complaints quickly so that an accurate clinical diagnosis can facilitate appropriate diagnostic measures and treatment. A focus on the neurologic causes of upper extremity pain (ie, cervical spine pathology, peripheral nerve compression, neuropathy) and musculoskeletal causes of shoulder and elbow pain (eg, adhesive capsulitis, calcific tendinitis, biceps tendinitis, synovitis) and the distinguishing characteristics (eg, periscapular pain, two-point discrimination, signal intensity on T2-weighted MRI) helps determine the appropriate diagnosis.


Subject(s)
Arthralgia/diagnosis , Musculoskeletal Pain/diagnosis , Physical Examination , Upper Extremity , Arthralgia/etiology , Diagnosis, Differential , Humans , Musculoskeletal Pain/etiology
4.
Spine J ; 13(3): 318-30, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23537454

ABSTRACT

BACKGROUND: Intervertebral disc (IVD) degeneration remains a clinically important condition for which treatment is costly and relatively ineffective. The molecular basis of degenerative disc disease has been an intense focus of research recently, which has greatly increased our understanding of the biology underlying this process. PURPOSE: To review the current understanding of the molecular basis of disc degeneration. STUDY DESIGN: Review article. METHODS: A literature review was performed to identify recent investigations and current knowledge regarding the molecular basis of IVD degeneration. RESULTS: The unique structural requirements and biochemical properties of the disc contribute to its propensity toward degeneration. Mounting evidence suggests that genetic factors account for up to 75% of individual susceptibility to IVD degeneration, far more than the environmental factors such as occupational exposure or smoking that were previously suspected to figure prominently in this process. Decreased extracellular matrix production, increased production of degradative enzymes, and increased expression of inflammatory cytokines contribute to the loss of structural integrity and accelerate IVD degeneration. Neurovascular ingrowth occurs, in part, because of the changing degenerative phenotype. CONCLUSIONS: A detailed understanding of the biology of IVD degeneration is essential to the design of therapeutic solutions to treat degenerative discs. Although significant advances have been made in explaining the biologic mediators of disc degeneration, the inhospitable biochemical environment of the IVD remains a challenging environment for biological therapies.


Subject(s)
Extracellular Matrix/metabolism , Intervertebral Disc Degeneration/metabolism , Intervertebral Disc/metabolism , Humans
5.
Spine (Phila Pa 1976) ; 37(3): 174-8, 2012 Feb 01.
Article in English | MEDLINE | ID: mdl-22293780

ABSTRACT

STUDY DESIGN: Retrospective review of 750 consecutive multilevel cervical spine decompression surgeries performed by a single spine surgeon. OBJECTIVE: To determine the incidence of C5 palsy in a large consecutive series of multilevel cervical spine decompression procedures. SUMMARY OF BACKGROUND DATA: Palsy of the C5 nerve is a well-known potential complication of cervical spine surgery with reported rates ranging from 0% to 30%. The etiology remains uncertain but has been attributed to iatrogenic injury during surgery, tethering from shifting of the spinal cord, spinal cord ischemia, and reperfusion injury of the spinal cord. METHODS: We included patients undergoing multilevel cervical corpectomy, corpectomy with posterior fusion, posterior laminectomy and fusion, and laminoplasty. Exclusion criteria included lack of follow-up data, spinal cord injury preventing preoperative or postoperative motor testing, or surgery not involving the C5 level. Incidence of C5 palsy was determined and compared to determine whether significant differences existed among the various procedures, patient age, sex, revision surgery, preoperative weakness, diabetes, smoking, number of levels decompressed, and history of previous upper extremity surgery. RESULTS: Of the 750 patients, 120 were eliminated on the basis of the exclusion criteria. The 630 patients included in the analysis consisted of 292 females and 338 males. The mean age was 58 years (range, 19-87). The incidence of C5 nerve palsy for the entire group was 42 of 630 (6.7%). The incidence was highest for the laminectomy and fusion group (9.5%), followed by the corpectomy with posterior fusion group (8.4%), the corpectomy group (5.1%), and finally the laminoplasty group (4.8%), although these differences did not reach statistical significance. There was a significantly higher incidence in males (8.6% vs. 4.5%, P = 0.05). CONCLUSION: Incidence of C5 nerve palsy after cervical spine decompression was 6.7%. This is consistent with previously published studies and represents the largest series of North American patients to date. There is no statistically significant difference in incidence of C5 palsy based on surgical procedure, although there was a trend toward higher rates with laminectomy and fusion.


Subject(s)
Brachial Plexus Neuropathies/epidemiology , Brachial Plexus/injuries , Decompression, Surgical/adverse effects , Intraoperative Complications/epidemiology , Spinal Nerve Roots/injuries , Spinal Nerve Roots/pathology , Adult , Aged , Aged, 80 and over , Brachial Plexus/pathology , Brachial Plexus/surgery , Cervical Vertebrae/surgery , Decompression, Surgical/methods , Female , Humans , Incidence , Male , Middle Aged , Retrospective Studies , Spinal Nerve Roots/surgery , Young Adult
6.
Arthritis Res Ther ; 13(5): R171, 2011.
Article in English | MEDLINE | ID: mdl-22018279

ABSTRACT

INTRODUCTION: Back pain, a significant source of morbidity in our society, is related to the degenerative changes of the intervertebral disc. At present, the treatment of disc disease consists of therapies that are aimed at symptomatic relief. This shortcoming stems in large part from our lack of understanding of the biochemical and molecular events that drive the disease process. The goal of this study is to develop a model of early disc degeneration using an organ culture. This approach is based on our previous studies that indicate that organ culture closely models molecular events that occur in vivo in an ex vivo setting. METHODS: To mimic a degenerative insult, discs were cultured under low oxygen tension in the presence of TNF-α, IL-1ß and serum limiting conditions. RESULTS: Treatment resulted in compromised cell survival and changes in cellular morphology reminiscent of degeneration. There was strong suppression in the expression of matrix proteins including collagen types 1, 2, 6 and 9, proteoglycans, aggrecan and fibromodulin. Moreover, a strong induction in expression of catabolic matrix metalloproteinases (MMP) 3, 9 and 13 with a concomitant increase in aggrecan degradation was seen. An inductive effect on NGF expression was also noticed. Although similar, nucleus pulposus and annulus fibrosus tissues showed some differences in their response to the treatment. CONCLUSIONS: Results of this study show that perturbations in microenvironmental factors result in anatomical and gene expression change within the intervertebral disc that may ultimately compromise cell function and induce pathological deficits. This system would be a valuable screening tool to investigate interventional strategies aimed at restoring disc cell function.


Subject(s)
Intervertebral Disc Degeneration/pathology , Intervertebral Disc/pathology , Lumbar Vertebrae/pathology , Animals , Cell Survival/physiology , Cellular Microenvironment/physiology , Intervertebral Disc/drug effects , Intervertebral Disc/metabolism , Intervertebral Disc Degeneration/metabolism , Lumbar Vertebrae/metabolism , Organ Culture Techniques/methods , Rats , Rats, Wistar
7.
J Am Acad Orthop Surg ; 19(9): 543-53, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21885700

ABSTRACT

Although understanding of the biologic basis of intervertebral disk (IVD) degeneration is rapidly advancing, the unique IVD environment presents challenges to the development and delivery of biologic treatments. Acceleration of cellular senescence and apoptosis in degenerative IVDs and the depletion of matrix proteins have prompted the development of treatments based on replacing IVD cells using various cell sources. However, this strategy has not been tested in animal models. IVD degeneration and associated pain have led to interest in pathologic innervation of the IVD and ultimately to the development of percutaneous devices to ablate afferent nerve endings in the posterior annulus. Degeneration leads to changes in the expression of matrix protein, cytokines, and proteinases. Injection of growth factors and mitogens may help overcome these degenerative changes in IVD phenotype, and these potential treatments are being explored in animal studies. Gene therapy is an elegant method to address changes in protein expression, but efforts to apply this technology to IVD degeneration are still at early stages.


Subject(s)
Biological Therapy/methods , Intervertebral Disc Degeneration/therapy , Animals , Apoptosis , Catheter Ablation/methods , Cellular Senescence , Cytokines/antagonists & inhibitors , Cytokines/metabolism , Electric Stimulation Therapy/methods , Extracellular Matrix/metabolism , Extracellular Matrix/pathology , Genetic Therapy/methods , Humans , Hyperthermia, Induced/methods , Intervertebral Disc/innervation , Intervertebral Disc/metabolism , Intervertebral Disc/pathology , Intervertebral Disc Degeneration/pathology , Platelet-Rich Plasma , Proteins/metabolism , Stem Cell Transplantation , Up-Regulation
8.
Spine (Phila Pa 1976) ; 36(17): 1387-91, 2011 Aug 01.
Article in English | MEDLINE | ID: mdl-21785303

ABSTRACT

STUDY DESIGN: Prospective study of 29 patients who underwent anterior cervical (AC) or posterior lumbar (PL) spinal surgery. A validated measure of dysphagia, the Swallowing-Quality of Life (SWAL-QOL) survey, was used to assess the degree of postoperative dysphagia. OBJECTIVE: To determine the degree of dysphagia preoperatively and postoperatively in patients undergoing AC surgery compared with a control group that underwent PL surgery. SUMMARY OF BACKGROUND DATA: Dysphagia is a well-known complication of AC spine surgery and has been shown to persist for up to 24 months or longer. METHODS: A total of 18 AC patients and a control group of 11 PL patients were prospectively enrolled in this study and were assessed preoperatively and at 3 weeks and 1.5 years postoperatively using a 14-item questionnaire from the SWAL-QOL survey to determine degree of dysphagia. Other patient factors and anesthesia records were examined to evaluate their relationship to dysphagia. RESULTS: There were no significant differences between the AC and PL groups with respect to age, sex, body mass index, or length of surgery. The SWAL-QOL scores at 3 weeks were significantly lower for the AC group than for the PL group (76 vs. 96; P = 0.001), but there were no differences between the groups preoperatively or at final follow-up. Smokers, patients with chronic obstructive pulmonary disease, and women had lower SWAL-QOL scores at one or more time point. CONCLUSION: Patients undergoing AC surgery had a significant increase in the degree of dysphagia 3 weeks after surgery compared with patients undergoing PL surgery. By final follow-up, swallowing in the AC group recovered to a level similar to preoperative and comparable to that in patients undergoing lumbar surgery at 1.5 years. Smoking, chronic obstructive pulmonary disease, and female sex are possible factors in the development of postoperative dysphagia.


Subject(s)
Cervical Vertebrae/surgery , Deglutition Disorders/psychology , Deglutition , Postoperative Complications/psychology , Quality of Life/psychology , Surveys and Questionnaires , Cohort Studies , Comorbidity , Deglutition/physiology , Deglutition Disorders/diagnosis , Deglutition Disorders/epidemiology , Diskectomy/adverse effects , Female , Follow-Up Studies , Humans , Male , Middle Aged , Postoperative Complications/diagnosis , Postoperative Complications/epidemiology , Prospective Studies , Surveys and Questionnaires/standards
10.
Spine (Phila Pa 1976) ; 35(17): E843-8, 2010 Aug 01.
Article in English | MEDLINE | ID: mdl-20628327

ABSTRACT

STUDY DESIGN: A structured questionnaire. OBJECTIVE: The purpose of this study was to determine whether material rod composition and its imaging characteristics can determine patient perceptions of pain, outcome, and need for revision surgery in the context of the failure of spinal instrumentation following lumbar arthrodesis. SUMMARY OF BACKGROUND DATA: Patient perceptions of radiographic images in the context of failed spinal instrumentation may influence clinical outcomes and patient satisfaction. Due to radiolucency, failed polyetheretherketone (PEEK) rods may be perceived differently by patients than more traditional materials. METHODS: Patients presenting primarily with chief complaints of back pain completed a 2-page, 22-question questionnaire containing 3 alternative radiographic images of failed rod instrumentation following posterolateral lumbar arthrodesis. The images represented failed rods composed of either PEEK, PEEK with a longitudinal radio-opaque marker, or traditional titanium. Statistical analysis with the Cochran Q test was performed to determine whether there were statistical differences in the responses. RESULTS: The responses suggested a preference for the images representing PEEK instrumentation as being associated with superior clinical outcomes, the least pain, the most comfort, and the least likelihood of required revision surgery. CONCLUSION: PEEK rods possess radiolucent properties that can alter patient perceptions of clinical outcomes when compared with images of other equally unfavorable scenarios. The significance of these patient perceptions must still be demonstrated. However, they may play an important role in clinical outcomes and patient satisfaction.


Subject(s)
Lumbar Vertebrae/surgery , Perception , Spinal Fusion/instrumentation , Benzophenones , Humans , Ketones , Low Back Pain/diagnostic imaging , Low Back Pain/surgery , Lumbar Vertebrae/diagnostic imaging , Polyethylene Glycols , Polymers , Radiography , Spinal Fusion/methods , Surveys and Questionnaires , Titanium , Treatment Outcome
11.
Spine (Phila Pa 1976) ; 35(6): 620-4, 2010 Mar 15.
Article in English | MEDLINE | ID: mdl-20150835

ABSTRACT

STUDY DESIGN: Retrospective analysis of a cohort of patients treated between April 2006 and January 2008, and diagnosed with cervical degenerative disease. OBJECTIVE: To determine the correlation of the clinical findings associated with cervical myelopathy to the presence of spinal cord compression or cord signal abnormalities on magnetic resonance imaging (MRI). SUMMARY OF BACKGROUND DATA: There are numerous reports describing the radiographic features of cervical spondylosis, however, no publication specifically describes the association between the physical signs of cervical myelopathy and the presenting imaging findings. METHODS: Myelopathy was defined as the presence of greater than one long-tract sign localized to the cervical spinal cord (Hoffman or Babinski signs, clonus, hyper-reflexia, crossed abductor sign, and/or gait dysfunction) on physical examination in the absence of other neurologic condition(s). The presence of these signs, MRI imaging features of spinal cord compression and hyperintense T2 intraparenchymal cord signal abnormality, and patient demographics were recorded. RESULTS: One hundred three patients met inclusion criteria (age >18, symptomatic cervical degenerative disease and complete neurologic assessment). Of these, 54 had clinical findings of cervical myelopathy. Radiographic features of cord compression were present in 62% of patients, and 84% had myelopathy on examination. No patients without cord compression presented with myelopathy (P < 0.0001). Thirty-five percent of the patients presented with hyperintense signal on T2 MRI within the spinal cord parenchyma. This finding correlated with the presence of myelopathy (P < 0.0001). Multivariate analysis on the subset with cord compression indicates that the likelihood of myelopathy increased with the presence of cord signal hyperintensity (odds ratio [OR], 11.4), sensory loss (OR, 16.9), and age (OR, 1.10 per year). CONCLUSION: The diagnosis of cervical myelopathy is based on presenting symptoms and physical examination. This analysis illustrates that radiographic cervical spinal cord compression and hyperintense T2 intraparen chymal signal abnormalities correlate with the presence of myelopathic findings on physical examination.


Subject(s)
Spinal Cord Compression/diagnosis , Spinal Cord Diseases/diagnosis , Spondylosis/diagnosis , Adult , Aged , Cervical Vertebrae/diagnostic imaging , Cervical Vertebrae/pathology , Female , Humans , Logistic Models , Magnetic Resonance Imaging , Male , Middle Aged , Multivariate Analysis , Radiography , Retrospective Studies , Spinal Cord Compression/diagnostic imaging , Spinal Cord Diseases/diagnostic imaging , Spondylosis/diagnostic imaging
12.
Spine (Phila Pa 1976) ; 35(3): 323-9, 2010 Feb 01.
Article in English | MEDLINE | ID: mdl-20075763

ABSTRACT

STUDY DESIGN: A survey on thromboprophylaxis in spinal surgery and trauma was conducted among spine trauma surgeons. OBJECTIVE: Neurosurgeons and orthopedic surgeons from the Spinal Trauma Study Group were surveyed in an attempt to understand current practices in the perioperative administration of thromboprophylaxis in spinal surgery. SUMMARY OF BACKGROUND DATA: Although much research has been invested in the prevention of thromboembolic events following surgical procedures, there have been few investigations specific to spinal surgery, especially in the context of trauma. METHODS: A total of 47 spine surgeons were provided with a 24-question survey pertaining to deep vein thrombosis prophylaxis in spine surgical patients. There was 100% response to the survey, and 46 of the 47 physicians (98%) responded to the case scenarios. RESULTS: Institutional protocols for deep vein thrombosis prophylaxis existed for 42 (89%) of the respondents; however, only 27 (57%) indicated that these protocols included spinal cord injury (SCI) patients. Before surgery, no prophylaxis or mechanical prophylactic measures for SCI and non-SCI spinal fracture patients were routinely used by 36 (77%) and 40 (85%) respondents, respectively. After surgery, pharmacologic prophylaxis was prescribed by 42 (91%) and 28 (62%) surgeons for SCI and non-SCI spinal fracture patients, respectively. There was a statistically significant tendency to use more intensive prophylactic measures for patients with SCI (x2, 10.86; P < 0.01) as well as a statistically significant longer duration of proposed thromboprophylaxis (x2, 24.62; P < 0.001). Postoperative pharmacologic thromboprophylaxis for elective anterior thoracolumbar spine surgery was reported by 23 (51%) of the respondents, whereas only 18 (40%) used pharmacological prophylaxis in elective posterior thoracolumbar spine cases. Spine complications from low-molecular weight heparin were reported by 22 (47%) surgeons, including fatal pulmonary embolism by 19 (40%) surgeons. CONCLUSION: A basis for a consensus protocol on thromboprophylaxis in spinal trauma was attempted. No more than mechanical prophylaxis was recommended before surgery for non-SCI patients or after surgery for elective cervical spine cases. Chemical prophylaxis was commonly used after surgery in patients with SCI and in patients with elective anterior thoracolumbar surgery.


Subject(s)
Elective Surgical Procedures/adverse effects , Physicians , Spinal Injuries/surgery , Surveys and Questionnaires , Thrombolytic Therapy/methods , Venous Thrombosis/prevention & control , Aged , Elective Surgical Procedures/methods , Female , Humans , Male , Middle Aged , Neurosurgical Procedures/adverse effects , Neurosurgical Procedures/methods , Orthopedic Procedures/adverse effects , Orthopedic Procedures/methods , Spinal Injuries/therapy , Venous Thrombosis/etiology , Young Adult
13.
Spine J ; 9(7): 530-6, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19251486

ABSTRACT

BACKGROUND CONTEXT: Although there are several studies evaluating the necessity and efficacy of thromboprophylaxis after spinal trauma with or without spinal cord injury (SCI), to date there is no established standard of practice pertaining to this specific patient population with regards to venous thromboembolism (VTE) prophylaxis. PURPOSE: To reach a consensus opinion in the administration of thromboprophylaxis in both preoperative and postoperative care in the settings of spinal trauma and SCI. STUDY DESIGN: A live survey on thromboprophylaxis after spinal surgery in the setting of trauma was conducted at a meeting among spine trauma surgeons. METHODS: Twenty-five spine surgeons (Neurosurgeons and Orthopedic surgeons), all members of the Spine Trauma Study Group, participated in a live survey in which they attempted to reach consensus pertaining to the management of deep vein thrombosis prophylaxis in patients with spine fractures (with and without a concomitant SCI). The consensus survey consisted of a 10-item questionnaire. Chi-square test was used for group comparisons in questionnaire responses. RESULTS: Complete agreement was reached for the need of postoperative pharmacologic thromboprophylaxis in cervical spine injuries with SCI and anterior thoracolumbar procedures with or without SCI. Postoperative pharmacologic thromboprophylaxis after cervical spine injuries without SCI was agreed not to be needed. In cases of delayed surgery for patients with SCI, pharmacologic thromboprophylaxis was recommended to be started as soon as possible in the presurgical period. The optimal duration of pharmacologic VTE prophylaxis was determined to be 3 months. Only 53% agreement was noted for the withholding of preoperative chemical prophylaxis in cervical or thoracolumbar spinal injuries with SCI (and 68% without SCI). Only 80% of the surgeons agreed that postoperative pharmacologic thromboprophylaxis is needed after posterior thoracolumbar procedures in patients with or without SCI. The use of vena cava filter after SCI was not universally recommended. CONCLUSIONS: Postoperative pharmacologic thromboprophylaxis was opined to be unnecessary in patients with cervical spine injuries without SCI, however, it is recommended for cervical spine trauma with SCI or anterior thoracolumbar procedures irrespective of SCI. Pharmacologic thromboprophylaxis was recommended to start preoperatively as soon as possible in SCI cases or in cases with surgical delay. Pharmacologic prophylaxis was recommended to be administered for at least 3 months postinjury. Although these recommendations met complete consensus by this group, individual patient factors should also be considered in determining optimal thromboprophylaxis in this patient population. Future research recommendations on thromboprophylaxis in spinal trauma are proposed.


Subject(s)
Neurosurgical Procedures/adverse effects , Orthopedic Procedures/adverse effects , Postoperative Complications/prevention & control , Spinal Cord Injuries/surgery , Spinal Injuries/surgery , Venous Thrombosis/prevention & control , Cervical Vertebrae , Humans , Practice Guidelines as Topic , Spinal Cord Injuries/etiology , Spinal Injuries/complications
14.
Spine J ; 9(3): 263-7, 2009 Mar.
Article in English | MEDLINE | ID: mdl-18838341

ABSTRACT

BACKGROUND CONTEXT: Polyetheretherketone (PEEK) has been increasingly used as a biomaterial for spinal implants. PEEK lumbar fusion rods have recently become available for use in posterior lumbar fusion procedures. PURPOSE: To compare Polyetheretherketone Rod System to traditional titanium rod fixation in a cadaveric model and provide mechanical test data for the PEEK system. STUDY DESIGN: Biomechanical testing. METHODS: Cadaveric biomechanical testing was conducted to compare Expedium 5.5 mm PEEK rods to titanium rods of equivalent diameter. Biomaterials testing was performed to determine static and dynamic performance of Expedium 5.5 mm PEEK rods with 6% BaSo4 in compressive bending and torsion. RESULTS: Cadaveric testing demonstrated that PEEK rods can significantly reduce the range of motion of a destabilized segment. The testing showed no significant difference in the stability provided by PEEK and titanium rods in posterolateral fusion (PLF) or posterior lumbar interbody fusion (PLIF) constructs. PEEK static compressive bending tests showed 67 degrees displacement without fracture of the rod. Torsion testing showed 30 degrees of rotation without yield or plastic deformation. Dynamic compression testing revealed two fatigue runouts at 23 degrees. CONCLUSIONS: PEEK rods provide comparable stability to titanium rods of equivalent diameter in cadaveric testing. Mechanical testing suggests PEEK rods can withstand far beyond the angular displacements suggested by cadaveric testing and that of normal physiologic range of motion. Potential advantages to PEEK rods include better anterior column load sharing, reduced stress at bone-to-screw interface, and reduced computed tomography and magnetic resonance imaging scatter and artifact.


Subject(s)
Biocompatible Materials , Ketones , Lumbar Vertebrae/surgery , Orthopedic Procedures/instrumentation , Polyethylene Glycols , Prostheses and Implants , Titanium , Benzophenones , Biomechanical Phenomena , Cadaver , Humans , Materials Testing , Polymers , Range of Motion, Articular
15.
SAS J ; 2(4): 159-70, 2008.
Article in English | MEDLINE | ID: mdl-25802618

ABSTRACT

STUDY DESIGN: This study is a systematic review of published biomechanical studies involving pedicle screw-based posterior dynamic stabilization devices (PDS) with a special focus on kinematics and load transmission through the functional spine unit (FSU). METHODS: A literature search was performed via the PubMed online database from 1990 to 2008 using the following key words: "biomechanics," "lumbar dynamic stabilization," "Graf system," "Dynesys," and "posterior dynamic implant." Citations were limited to papers describing biomechanics of pedicle screw-based PDS devices currently available for clinical use. Studies describing clinical experience, radiology, and in vivo testing were excluded from the review. Parameters measured included kinematics of the FSU (range of motion (ROM), neutral zone (NZ), and location of the center of rotation) and load transmission through the disk, facets, and instrumentation. RESULTS: A total of 27 publications were found that concerned the biomechanical evaluation of lumbar pedicle screw-based dynamic stabilization instrumentation. Nine in vitro experimental studies and 4 finite element analyses satisfied the inclusion criteria. The Dynesys implant was the most investigated pedicle screw-based PDS system. In vitro cadaveric studies mainly focused on kinematics comparing ROM of intact versus instrumented spines whereas finite element analyses allowed analysis of load transmission at the instrumented and adjacent levels. CONCLUSION: Biomechanical studies demonstrate that pedicle screw-based PDS devices limit intervertebral motion while unloading the intervertebral disk. The implant design and the surgical technique have a significant impact on the biomechanical behavior of the instrumented spinal segment. The posterior placement of such devices results in non-physiologic intervertebral kinematics with a posterior shift of the axis of rotation. Biomechanical studies suggest that the difference at the adjacent level between investigated dynamic devices and rigid stabilization systems may not be as high as reported. Finally, additional investigations of semirigid devices are needed to further evaluate their biomechanical properties compared to soft stabilization PDS systems.

SELECTION OF CITATIONS
SEARCH DETAIL
...